Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingcai Meng

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Journal of Hematology & Oncology|August 12, 2020
Ferroptosis, necroptosis, and pyroptosis in anticancer immunityRong Tang, Jin Xu, Bo Zhang, et al.
Molecular Cancer|December 14, 2019
The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implicationsXiaomeng Liu, Jin Xu, Bo Zhang, et al.
Oncotargets and Therapy|August 21, 2018
Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?Jie Hua, Si Shi, Dingkong Liang, et al.
Journal of Cancer|August 16, 2019
Nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic cancer: a systematic review and meta-analysisYiyin Zhang, Jin Xu, Jie Hua, et al.
Cell Death & Disease|December 13, 2018
GPx1 is involved in the induction of protective autophagy in pancreatic cancer cells in response to glucose deprivationQingcai Meng, Jin Xu, Chen Liang, et al.
Annals of Translational Medicine|December 14, 2020
The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancerRong Tang, Jie Hua, Jin Xu, et al.
BMC Cancer|December 30, 2025
Constructing a machine learning model for predicting early postoperative recurrence of pancreatic head cancer based on a novel inflammatory factor composite indexChengkai Yang, Miaoyan Wei, Qingcai Meng, et al.
Molecular Cell|October 4, 2016
USP38 Inhibits Type I Interferon Signaling by Editing TBK1 Ubiquitination through NLRP4 SignalosomeMeng Lin, Zhiyao Zhao, Zhifen Yang, et al.
Computational and Structural Biotechnology Journal|May 8, 2023
Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CTQingcai Meng, Zengli Fang, Xiaoqi Mao, et al.
Nature Communications|November 26, 2025
Itaconate transport across the plasma membrane and Salmonella-containing vacuole via MCT1/4 modulates macrophage antibacterial activityQingcai Meng, Chengxi Li, Yuping Cai, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Journal of Hematology & Oncology|August 12, 2020
Ferroptosis, necroptosis, and pyroptosis in anticancer immunityRong Tang, Jin Xu, Bo Zhang, et al.
Molecular Cancer|December 14, 2019
The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implicationsXiaomeng Liu, Jin Xu, Bo Zhang, et al.
Oncotargets and Therapy|August 21, 2018
Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?Jie Hua, Si Shi, Dingkong Liang, et al.
Journal of Cancer|August 16, 2019
Nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic cancer: a systematic review and meta-analysisYiyin Zhang, Jin Xu, Jie Hua, et al.
Cell Death & Disease|December 13, 2018
GPx1 is involved in the induction of protective autophagy in pancreatic cancer cells in response to glucose deprivationQingcai Meng, Jin Xu, Chen Liang, et al.
Annals of Translational Medicine|December 14, 2020
The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancerRong Tang, Jie Hua, Jin Xu, et al.
BMC Cancer|December 30, 2025
Constructing a machine learning model for predicting early postoperative recurrence of pancreatic head cancer based on a novel inflammatory factor composite indexChengkai Yang, Miaoyan Wei, Qingcai Meng, et al.
Molecular Cell|October 4, 2016
USP38 Inhibits Type I Interferon Signaling by Editing TBK1 Ubiquitination through NLRP4 SignalosomeMeng Lin, Zhiyao Zhao, Zhifen Yang, et al.
Computational and Structural Biotechnology Journal|May 8, 2023
Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CTQingcai Meng, Zengli Fang, Xiaoqi Mao, et al.
Nature Communications|November 26, 2025
Itaconate transport across the plasma membrane and Salmonella-containing vacuole via MCT1/4 modulates macrophage antibacterial activityQingcai Meng, Chengxi Li, Yuping Cai, et al.
Pageof 9